Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Review Article
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 7625982, 2 pages
http://dx.doi.org/10.1155/2016/7625982
Letter to the Editor

Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”

Hepatobiliary Surgery Department, Affiliated Tumor Hospital, Guangxi Medical University, Nanning 530021, China

Received 10 January 2016; Accepted 7 April 2016

Academic Editor: Eric M. Yoshida

Copyright © 2016 Han-Yue Mo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Yuan, P. Chen, and Y. Qian, “Evaluation of antiviral therapy performed after curative therapy in patients with HBV-related hepatocellular carcinoma: an updated meta-analysis,” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 5234969, 11 pages, 2016. View at Publisher · View at Google Scholar
  2. J.-H. Zhong, Y. Ke, W.-F. Gong et al., “Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma,” Annals of Surgery, vol. 260, no. 2, pp. 329–340, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Huang, W. Y. Lau, Z. G. Wang et al., “Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial,” Annals of Surgery, vol. 261, no. 1, pp. 56–66, 2015. View at Google Scholar
  4. J. Yin, N. Li, Y. Han et al., “Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study,” Journal of Clinical Oncology, vol. 31, no. 29, pp. 3647–3655, 2013. View at Publisher · View at Google Scholar
  5. J.-H. Zhong, “Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions,” Tumour Biology, vol. 35, no. 12, pp. 12779–12784, 2014. View at Publisher · View at Google Scholar · View at Scopus